Emerging evidence supports the argument that psoriatic arthritis arises from two pathways and that affected immune cells may ...
A study of biologic-naive patients with psoriasis or PsA found that IL-17, IL-12/23, and IL-23 inhibitors have comparable cardiovascular and thrombotic risk profiles as TNF inhibitors.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback